Stocks and Investing
Stocks and Investing
Tue, February 12, 2013
[ 07:45 AM ] - United States, WOPRAI
[ 06:40 AM ] - United States, Market Wire
[ 06:30 AM ] - United States, Market Wire
[ 05:45 AM ] - United States, WOPRAI
[ 05:45 AM ] - United States, WOPRAI
[ 05:31 AM ] - United States, Market Wire
[ 04:48 AM ] - United States, WOPRAI
[ 04:47 AM ] - United States, WOPRAI
[ 04:47 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 03:48 AM ] - United States, WOPRAI
[ 03:48 AM ] - United States, WOPRAI
[ 03:47 AM ] - United States, WOPRAI
[ 03:47 AM ] - United States, WOPRAI
[ 03:46 AM ] - United States, WOPRAI
[ 03:46 AM ] - United States, WOPRAI
[ 03:46 AM ] - United States, WOPRAI
[ 03:45 AM ] - United States, WOPRAI
[ 03:45 AM ] - United States, WOPRAI
[ 01:03 AM ] - United States, Market Wire
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michelle Gilson Maintained (BMRN) at Strong Buy with Increased Target to $71 on, Feb 12th, 2013
Michelle Gilson of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $56 to $71 on, Feb 12th, 2013.
Michelle has made no other calls on BMRN in the last 4 months.
There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Michelle's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Michelle
- Martin Auster of "UBS" Maintained at Strong Buy with Increased Target to $67 on, Friday, February 1st, 2013
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $54 on, Tuesday, November 6th, 2012
Contributing Sources